In Reply to ‘High-Dose Versus Standard-Dose Influenza Vaccine in Hemodialysis Patients’

Anne M. Butler; J. Bradley Layton; Vikas R. Dharnidharka; Leah J. McGrath

doi:10.1053/j.ajkd.2019.11.002

In Reply to ‘High-Dose Versus Standard-Dose Influenza Vaccine in Hemodialysis Patients’

Anne M. Butler, J. Bradley Layton, Vikas R. Dharnidharka, Leah J. McGrath

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	456-457
Number of pages	2
Journal	American Journal of Kidney Diseases
Volume	75
Issue number	3
DOIs	https://doi.org/10.1053/j.ajkd.2019.11.002
State	Published - Mar 2020

Access to Document

10.1053/j.ajkd.2019.11.002

Cite this

@article{5aa7b3304cf345b0bac0d7860af361d4,

title = "In Reply to {\textquoteleft}High-Dose Versus Standard-Dose Influenza Vaccine in Hemodialysis Patients{\textquoteright}",

author = "Butler, {Anne M.} and Layton, {J. Bradley} and Dharnidharka, {Vikas R.} and McGrath, {Leah J.}",

note = "Funding Information: Dr Layton is an employee of RTI International, an independent nonprofit research organization that performs research on behalf of government and commercial clients, including pharmaceutical companies. Dr McGrath is an employee of NoviSci, a data sciences company, and previously was an employee of RTI Health Solutions. The remaining authors declare that they have no relevant financial interests. Received October 12, 2019. Direct editorial input from a Statistical Editor, an Associate Editor, and a Deputy Editor. Accepted in revised form November 27, 2019.",

year = "2020",

month = mar,

doi = "10.1053/j.ajkd.2019.11.002",

language = "English",

volume = "75",

pages = "456--457",

journal = "American Journal of Kidney Diseases",

issn = "0272-6386",

number = "3",

}

TY - JOUR

T1 - In Reply to ‘High-Dose Versus Standard-Dose Influenza Vaccine in Hemodialysis Patients’

AU - Butler, Anne M.

AU - Layton, J. Bradley

AU - Dharnidharka, Vikas R.

AU - McGrath, Leah J.

N1 - Funding Information: Dr Layton is an employee of RTI International, an independent nonprofit research organization that performs research on behalf of government and commercial clients, including pharmaceutical companies. Dr McGrath is an employee of NoviSci, a data sciences company, and previously was an employee of RTI Health Solutions. The remaining authors declare that they have no relevant financial interests. Received October 12, 2019. Direct editorial input from a Statistical Editor, an Associate Editor, and a Deputy Editor. Accepted in revised form November 27, 2019.

PY - 2020/3

Y1 - 2020/3

UR - http://www.scopus.com/inward/record.url?scp=85079240501&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2019.11.002

DO - 10.1053/j.ajkd.2019.11.002

M3 - Letter

C2 - 31980252

AN - SCOPUS:85079240501

SN - 0272-6386

VL - 75

SP - 456

EP - 457

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

IS - 3

ER -

In Reply to ‘High-Dose Versus Standard-Dose Influenza Vaccine in Hemodialysis Patients’

Access to Document

Other files and links

Cite this